ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 284751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 284751; 2) Community: the network communities that were significantly associated with the response to NSC 284751; 3) Molecule: the relationships between components within communities and NSC 284751; 4) MDR: the compounds that were significantly associated with the NSC 284751.

NSC Compound Enrichment Correlation
NSC 670786 Null 0.0388857481216096 0.49231222
NSC 671030 N8-Actinomycin D 0.0388857481216096 0.14947076
NSC 683247 Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.0388857481216096 0.41354599
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.0388857481216096 0.48416615
NSC 686556 Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- 0.0388857481216096 -0.10703229
NSC 692587 ethyl-8-(4-chlorophenyl)-4-methyl-2-oxo-6-(thiophen-2-yl)-4a,7-dihydro-2H-chromene-3- carboxylate 0.0388857481216096 0.38742802
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0388857481216096 0.47081533
NSC 740252 Null 0.0388857481216096 0.39473488
NSC 763587 Null 0.0388857481216096 0.37433726
NSC 174121 Methotrexate Derivative 0.03888574812161 0.34804303
Total:146  Current:114    [First] [Prev] [Next] [Last]